Cost Effectiveness of Budesonide/Formoterol for Maintenance and Reliever Therapy versus Salmeterol/Fluticasone plus Salbutamol in the Treatment of Asthma-Reference-Cited by-同舟云学术

Cost Effectiveness of Budesonide/Formoterol for Maintenance and Reliever Therapy versus Salmeterol/Fluticasone plus Salbutamol in the Treatment of Asthma

Published:2006 Issue:7 Volume:24 Page:695-708
ISSN:1170-7690
Container-title:PharmacoEconomics
language:en
Short-container-title:PharmacoEconomics

Author:

Johansson Gunnar,Andreasson Emma B,Larsson Per E,Vogelmeier Claus F

Publisher

Springer Science and Business Media LLC

Subject

Public Health, Environmental and Occupational Health,Health Policy,Pharmacology

Reference8 articles.

1. Combination Therapy with Single Inhaler Budesonide/Formoterol Compared with High Dose of Fluticasone Propionate Alone in Patients with Moderate Persistent Asthma

2. Impiego di un’associazione fissa di formoterolo e budesonide nel trattamento del paziente asmatico

3. Assessment Methods for Patient-Reported Outcomes

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Budesonide/formoterol maintenance and reliever therapy in childhood asthma: Real‐world effectiveness and economic assessment;Pediatric Pulmonology;2023-10-11

2. Open and Closed Triple Inhaler Therapy in Patients with Uncontrolled Asthma;Advances in Respiratory Medicine;2023-07-04

3. Budesonide/formoterol maintenance and reliever therapy versus fluticasone/salmeterol fixed-dose treatment in patients with COPD;Thorax;2023-02-01

4. Introduction of the telemonitoring device Turbo+ in the management of patients suffering from asthma in Italy: a budget impact analysis;Global & Regional Health Technology Assessment;2022-04-19

5. Treatments for poorly controlled asthma;BMJ;2021-10-04